on Eckert & Ziegler Strahlen- Und Medizintechnik AG (isin : DE0005659700)
Eckert & Ziegler Reports Growth in Sales and Earnings for First Nine Months of 2024
In the first nine months of 2024, Eckert & Ziegler SE recorded sales of EUR 215.5 million, showing an improvement from EUR 183.9 million the previous year. The company also reported an EBIT before special items of EUR 46.7 million versus EUR 37.7 million in 2023. However, net income for the third quarter fell to EUR 5.3 million from EUR 9.4 million in the same period last year.
The Berlin-based company, listed on TecDAX, anticipates maintaining its forecasted sales for 2024 at just below EUR 265 million and an EBIT of around EUR 55 million. Full financial results for the first nine months are scheduled for release on November 14, 2024.
R. H.
Copyright © 2024 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Eckert & Ziegler Strahlen- Und Medizintechnik AG news